FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jose Perez-Simon

Research Profile

Disorders

Procedures

Concepts & Ideas

Phenomena

Recurrence

Living Beings

Chemicals & Drugs

Gallium Radioisotopes

Anatomy

Cells, Cultured

Co-author Network

Publications

TOP 3
Fermin Sanchez-Guijo; Enrique Oterino; Maria-Victoria Barbado; Soraya Carrancio; Natalia Lopez-Holgado; Sandra Muntion; Pilar Hernandez-Campo; Luis-Ignacio Sanchez-Abarca; Jose A Perez-Simon; Jesús F San Miguel; Jesús G Briñon; Maria Consuelo Del Cañizo
Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells.
O Lopez-Villar; J L Garcia; Fermin Sanchez-Guijo; Cristina Robledo; Eva Villaron; P Hernández-Campo; Natalia Lopez-Holgado; M Diez-Campelo; M V Barbado; Jose A Perez-Simon; J M Hernández-Rivas; Jesús F San Miguel; Maria Consuelo Del Cañizo
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
Julio Delgado; Srinivas Pillai; Reuben Benjamin; Dolores Caballero; Rodrigo Martino; Amit Nathwani; Richard Lovell; Kirsty Thomson; Jose A Perez-Simon; Anna Sureda; Panagiotis Kottaridis; Lourdes Vazquez; Karl Peggs; Jorge Sierra; Donald Milligan; Stephen Mackinnon
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jose Perez-Simon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Fermin Sanchez-Guijo; Enrique Oterino; Maria-Victoria Barbado; Soraya Carrancio; Natalia Lopez-Holgado; Sandra Muntion; Pilar Hernandez-Campo; Luis-Ignacio Sanchez-Abarca; Jose A Perez-Simon; Jesús F San Miguel; Jesús G Briñon; Maria Consuelo Del Cañizo
Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells.
Cell transplantation 2010;19(1):103-12.
2009: O Lopez-Villar; J L Garcia; Fermin Sanchez-Guijo; Cristina Robledo; Eva Villaron; P Hernández-Campo; Natalia Lopez-Holgado; M Diez-Campelo; M V Barbado; Jose A Perez-Simon; J M Hernández-Rivas; Jesús F San Miguel; Maria Consuelo Del Cañizo
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
Leukemia 2009;23(4):664-72.
2008: Julio Delgado; Srinivas Pillai; Reuben Benjamin; Dolores Caballero; Rodrigo Martino; Amit Nathwani; Richard Lovell; Kirsty Thomson; Jose A Perez-Simon; Anna Sureda; Panagiotis Kottaridis; Lourdes Vazquez; Karl Peggs; Jorge Sierra; Donald Milligan; Stephen Mackinnon
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1288-97.
2008: Francis Ayuk; Jose A Perez-Simon; Avichai Shimoni; Anna Sureda; Tatjana Zabelina; Rainer Schwerdtfeger; Rodrigo Martino; Herbert G Sayer; Adrián Alegre; Juan José Lahuerta; Djordje Atanackovic; Christine Wolschke; Arnon Nagler; Axel R Zander; Jesús F San Miguel; Nicolaus Kröger
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica 2008;93(9):1343-50.
2008: Jose R Gonzalez-Porras; Ignacio F Graciani; Jose A Perez-Simon; Jesus Martin-Sanchez; Cristina Encinas; Maria P Conde; Maria J Nieto; Mercedes Corral
Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients.
Transfusion 2008;48(7):1318-24.
2008: Ignacio G Escobar; Pilar T Alonso; Dolores C Barrigon; Jose A Perez-Simon; Maria V Mateos Manteca; Jesus F San Miguel Izquierdo
Prognostic impact of pre-transplantation computed tomography and 67gallium scanning in chemosensitive diffuse large B cell lymphoma patients undergoing hematopoietic stem-cell transplantation.
Annals of nuclear medicine 2008;22(4):251-60.
2007: Eva Villaron; Julia Almeida; Natalia Lopez-Holgado; Fermin Sanchez-Guijo; Mercedes Alberca; Belén Blanco; Luis-Ignacio Sanchez-Abarca; O Lopez; Jose A Perez-Simon; Jesús F San Miguel; Maria Consuelo Del Cañizo
In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2007;37(2):145-56.
2006: Ignacio Garcia Escobar; Dolores Caballero Barrigon; Pilar Tamayo; Jose A Perez-Simon; Maria Vitoria Mateos; Jose Ramon Garcia; Jesús F San Miguel
Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
Clinical lymphoma & myeloma 2006;7(3):217-25.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2006;37(12):1135-41.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Blood 2006;107(8):3415-6.
2006: Eva Villaron; Jose A Perez-Simon; Jesús F San Miguel; Consuelo del Cañizo
Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation.
Experimental hematology 2006;34(1):7.
2005: Fermin Sanchez-Guijo; Luis-Ignacio Sanchez-Abarca; Eva Villaron; Natalia Lopez-Holgado; Mercedes Alberca; Lourdes Vazquez; Jose A Perez-Simon; Jesus Lopez-Fidalgo; Alberto Orfao; María Dolores Caballero; Maria Consuelo Del Cañizo; Jesús F San Miguel
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability.
Experimental hematology 2005;33(8):935-43.
2005: Fermin Sanchez-Guijo; Luis-Ignacio Sanchez-Abarca; Clara Bueno; Eva Villaron; Natalia Lopez-Holgado; Lourdes Vazquez; Jesus Lopez-Fidalgo; Jose A Perez-Simon; María Dolores Caballero; Maria Consuelo Del Cañizo; Alberto Orfao; Jesús F San Miguel
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):354-61.
2004: Nicolaus Kröger; Jose A Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimoni; Arnon Nagler; Rodrigo Martino; Adrian Alegre; Jose F Tomas; Rainer Schwerdtfeger; Michael Kiehl; Axel A Fauser; Herbert G Sayer; Angel Leon; Jörg Beyer; Tatjana Zabelina; Francis Ayuk; Jesús F San Miguel; Ronald Brand; Axel R Zander
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
2004: J Rodriguez; María Dolores Caballero; A Gutierrez; Carlos Solano; Reyes Arranz; Juan José Lahuerta; Jorge Sierra; Marcos Gandarillas; Jose A Perez-Simon; Javier Zuazu; Armando Lopez-Guillermo; Anna Sureda; Enric Carreras; J Garcia-Laraña; J Marin; J C Garcia; A Fernandez De Sevilla; J Rifon; R Varela; Isidro Jarque; Carmen Albo; Angel Leon; J SanMiguel; Eulogio Conde
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1504-9.
2004: Nicolaus Kröger; Georgia Schilling; Hermann Einsele; Peter Liebisch; Avichai Shimoni; Arnon Nagler; Jose A Perez-Simon; Jesús F San Miguel; Michael Kiehl; Axel A Fauser; Rainer Schwerdtfeger; Hannes Wandt; Herbert G Sayer; Han Myint; Hans Klingemann; Tatjana Zabelina; Judith Dierlamm; Axel Hinke; Axel R Zander
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Blood 2004;103(11):4056-61.
2003: Jose A Perez-Simon; Maria Diez-Campelo; Rodrigo Martino; Anna Sureda; Dolores Caballero; Consuelo Canizo; Salut Brunet; Albert Altes; Lourdes Vazquez; Jorge Sierra; Jesus F San Miguel
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.
Blood 2003;102(3):1108-13.